Ace Therapeutics recently underscored its commitment to advancing chronic kidney disease (CKD) therapeutic development by offering one-stop CKD contract research services with a robust portfolio of ...

Serial infusions to restore amniotic fluid lost due to lack of fetal renal development before 26 weeks' gestation improved the rate of live births without maternal safety risks, the RAFT trial found.

Congenital heart defects (CHD) are developmental and functional abnormalities of an infant's heart at birth. CHD are the most common type of birth defect affecting approximately 1 in every 115 babies.